Global Non-invasive Insulin Market Growth 2026-2032
The global Non-invasive Insulin market size is predicted to grow from US$ 2151 million in 2025 to US$ 5886 million in 2032; it is expected to grow at a CAGR of 15.8% from 2026 to 2032.
Non-invasive insulin refers to insulin delivery methods that do not require traditional subcutaneous injections. These alternatives are developed to improve patient comfort and compliance. Common forms of non-injectable insulin include inhalable insulin, such as Afrezza, which is absorbed through the lungs, and oral insulin, which is being researched to survive the digestive tract and be absorbed into the bloodstream. These methods aim to offer more convenient and less invasive options for managing diabetes, reducing the burden of frequent injections, and potentially enhancing the quality of life for patients.
United States market for Non-invasive Insulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Non-invasive Insulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Non-invasive Insulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Non-invasive Insulin players cover Novo Nordisk, Sanofi, Eli Lilly, MannKind Corporation, Biocon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Non-invasive Insulin Industry Forecast? looks at past sales and reviews total world Non-invasive Insulin sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-invasive Insulin sales for 2026 through 2032. With Non-invasive Insulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Insulin industry.
This Insight Report provides a comprehensive analysis of the global Non-invasive Insulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive Insulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-invasive Insulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Insulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Insulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Insulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Non-invasive Insulin market?
What factors are driving Non-invasive Insulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-invasive Insulin market opportunities vary by end market size?
How does Non-invasive Insulin break out by Type, by Application?
Non-invasive insulin refers to insulin delivery methods that do not require traditional subcutaneous injections. These alternatives are developed to improve patient comfort and compliance. Common forms of non-injectable insulin include inhalable insulin, such as Afrezza, which is absorbed through the lungs, and oral insulin, which is being researched to survive the digestive tract and be absorbed into the bloodstream. These methods aim to offer more convenient and less invasive options for managing diabetes, reducing the burden of frequent injections, and potentially enhancing the quality of life for patients.
United States market for Non-invasive Insulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Non-invasive Insulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Non-invasive Insulin is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Non-invasive Insulin players cover Novo Nordisk, Sanofi, Eli Lilly, MannKind Corporation, Biocon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Non-invasive Insulin Industry Forecast? looks at past sales and reviews total world Non-invasive Insulin sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-invasive Insulin sales for 2026 through 2032. With Non-invasive Insulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Insulin industry.
This Insight Report provides a comprehensive analysis of the global Non-invasive Insulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive Insulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-invasive Insulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Insulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Insulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Insulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Pills
- Sprays
- Others
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Sanofi
- Eli Lilly
- MannKind Corporation
- Biocon
- Janssen Pharmaceuticals
- Adocia
- Oramed Pharmaceuticals
- Dance Biopharm
- Medtronic
- Verily Life Sciences
- Zafgen
- Senseonics
- Bigfoot Biomedical
What is the 10-year outlook for the global Non-invasive Insulin market?
What factors are driving Non-invasive Insulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-invasive Insulin market opportunities vary by end market size?
How does Non-invasive Insulin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive Insulin Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-invasive Insulin by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-invasive Insulin by Country/Region, 2021, 2025 & 2032
2.2 Non-invasive Insulin Segment by Type
2.2.1 Pills
2.2.2 Sprays
2.2.3 Others
2.2.4 Non-invasive Insulin Sales by Type
2.2.4.1 Global Non-invasive Insulin Sales Market Share by Type (2021-2026)
2.2.4.2 Global Non-invasive Insulin Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Non-invasive Insulin Sale Price by Type (2021-2026)
2.3 Non-invasive Insulin Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Online Pharmacies
2.3.3 Drug Stores
2.3.4 Non-invasive Insulin Sales by Application
2.3.4.1 Global Non-invasive Insulin Sale Market Share by Application (2021-2026)
2.3.4.2 Global Non-invasive Insulin Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Non-invasive Insulin Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-invasive Insulin Breakdown Data by Company
3.1.1 Global Non-invasive Insulin Annual Sales by Company (2021-2026)
3.1.2 Global Non-invasive Insulin Sales Market Share by Company (2021-2026)
3.2 Global Non-invasive Insulin Annual Revenue by Company (2021-2026)
3.2.1 Global Non-invasive Insulin Revenue by Company (2021-2026)
3.2.2 Global Non-invasive Insulin Revenue Market Share by Company (2021-2026)
3.3 Global Non-invasive Insulin Sale Price by Company
3.4 Key Manufacturers Non-invasive Insulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-invasive Insulin Product Location Distribution
3.4.2 Players Non-invasive Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-INVASIVE INSULIN BY GEOGRAPHIC REGION
4.1 World Historic Non-invasive Insulin Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-invasive Insulin Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-invasive Insulin Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-invasive Insulin Market Size by Country/Region (2021-2026)
4.2.1 Global Non-invasive Insulin Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-invasive Insulin Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-invasive Insulin Sales Growth
4.4 APAC Non-invasive Insulin Sales Growth
4.5 Europe Non-invasive Insulin Sales Growth
4.6 Middle East & Africa Non-invasive Insulin Sales Growth
5 AMERICAS
5.1 Americas Non-invasive Insulin Sales by Country
5.1.1 Americas Non-invasive Insulin Sales by Country (2021-2026)
5.1.2 Americas Non-invasive Insulin Revenue by Country (2021-2026)
5.2 Americas Non-invasive Insulin Sales by Type (2021-2026)
5.3 Americas Non-invasive Insulin Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Insulin Sales by Region
6.1.1 APAC Non-invasive Insulin Sales by Region (2021-2026)
6.1.2 APAC Non-invasive Insulin Revenue by Region (2021-2026)
6.2 APAC Non-invasive Insulin Sales by Type (2021-2026)
6.3 APAC Non-invasive Insulin Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-invasive Insulin by Country
7.1.1 Europe Non-invasive Insulin Sales by Country (2021-2026)
7.1.2 Europe Non-invasive Insulin Revenue by Country (2021-2026)
7.2 Europe Non-invasive Insulin Sales by Type (2021-2026)
7.3 Europe Non-invasive Insulin Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive Insulin by Country
8.1.1 Middle East & Africa Non-invasive Insulin Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-invasive Insulin Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-invasive Insulin Sales by Type (2021-2026)
8.3 Middle East & Africa Non-invasive Insulin Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-invasive Insulin
10.3 Manufacturing Process Analysis of Non-invasive Insulin
10.4 Industry Chain Structure of Non-invasive Insulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-invasive Insulin Distributors
11.3 Non-invasive Insulin Customer
12 WORLD FORECAST REVIEW FOR NON-INVASIVE INSULIN BY GEOGRAPHIC REGION
12.1 Global Non-invasive Insulin Market Size Forecast by Region
12.1.1 Global Non-invasive Insulin Forecast by Region (2027-2032)
12.1.2 Global Non-invasive Insulin Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-invasive Insulin Forecast by Type (2027-2032)
12.7 Global Non-invasive Insulin Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Non-invasive Insulin Product Portfolios and Specifications
13.1.3 Novo Nordisk Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Non-invasive Insulin Product Portfolios and Specifications
13.2.3 Sanofi Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Eli Lilly
13.3.1 Eli Lilly Company Information
13.3.2 Eli Lilly Non-invasive Insulin Product Portfolios and Specifications
13.3.3 Eli Lilly Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Eli Lilly Main Business Overview
13.3.5 Eli Lilly Latest Developments
13.4 MannKind Corporation
13.4.1 MannKind Corporation Company Information
13.4.2 MannKind Corporation Non-invasive Insulin Product Portfolios and Specifications
13.4.3 MannKind Corporation Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MannKind Corporation Main Business Overview
13.4.5 MannKind Corporation Latest Developments
13.5 Biocon
13.5.1 Biocon Company Information
13.5.2 Biocon Non-invasive Insulin Product Portfolios and Specifications
13.5.3 Biocon Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Biocon Main Business Overview
13.5.5 Biocon Latest Developments
13.6 Janssen Pharmaceuticals
13.6.1 Janssen Pharmaceuticals Company Information
13.6.2 Janssen Pharmaceuticals Non-invasive Insulin Product Portfolios and Specifications
13.6.3 Janssen Pharmaceuticals Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Janssen Pharmaceuticals Main Business Overview
13.6.5 Janssen Pharmaceuticals Latest Developments
13.7 Adocia
13.7.1 Adocia Company Information
13.7.2 Adocia Non-invasive Insulin Product Portfolios and Specifications
13.7.3 Adocia Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Adocia Main Business Overview
13.7.5 Adocia Latest Developments
13.8 Oramed Pharmaceuticals
13.8.1 Oramed Pharmaceuticals Company Information
13.8.2 Oramed Pharmaceuticals Non-invasive Insulin Product Portfolios and Specifications
13.8.3 Oramed Pharmaceuticals Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Oramed Pharmaceuticals Main Business Overview
13.8.5 Oramed Pharmaceuticals Latest Developments
13.9 Dance Biopharm
13.9.1 Dance Biopharm Company Information
13.9.2 Dance Biopharm Non-invasive Insulin Product Portfolios and Specifications
13.9.3 Dance Biopharm Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Dance Biopharm Main Business Overview
13.9.5 Dance Biopharm Latest Developments
13.10 Medtronic
13.10.1 Medtronic Company Information
13.10.2 Medtronic Non-invasive Insulin Product Portfolios and Specifications
13.10.3 Medtronic Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Medtronic Main Business Overview
13.10.5 Medtronic Latest Developments
13.11 Verily Life Sciences
13.11.1 Verily Life Sciences Company Information
13.11.2 Verily Life Sciences Non-invasive Insulin Product Portfolios and Specifications
13.11.3 Verily Life Sciences Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Verily Life Sciences Main Business Overview
13.11.5 Verily Life Sciences Latest Developments
13.12 Zafgen
13.12.1 Zafgen Company Information
13.12.2 Zafgen Non-invasive Insulin Product Portfolios and Specifications
13.12.3 Zafgen Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zafgen Main Business Overview
13.12.5 Zafgen Latest Developments
13.13 Senseonics
13.13.1 Senseonics Company Information
13.13.2 Senseonics Non-invasive Insulin Product Portfolios and Specifications
13.13.3 Senseonics Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Senseonics Main Business Overview
13.13.5 Senseonics Latest Developments
13.14 Bigfoot Biomedical
13.14.1 Bigfoot Biomedical Company Information
13.14.2 Bigfoot Biomedical Non-invasive Insulin Product Portfolios and Specifications
13.14.3 Bigfoot Biomedical Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Bigfoot Biomedical Main Business Overview
13.14.5 Bigfoot Biomedical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive Insulin Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-invasive Insulin by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-invasive Insulin by Country/Region, 2021, 2025 & 2032
2.2 Non-invasive Insulin Segment by Type
2.2.1 Pills
2.2.2 Sprays
2.2.3 Others
2.2.4 Non-invasive Insulin Sales by Type
2.2.4.1 Global Non-invasive Insulin Sales Market Share by Type (2021-2026)
2.2.4.2 Global Non-invasive Insulin Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Non-invasive Insulin Sale Price by Type (2021-2026)
2.3 Non-invasive Insulin Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Online Pharmacies
2.3.3 Drug Stores
2.3.4 Non-invasive Insulin Sales by Application
2.3.4.1 Global Non-invasive Insulin Sale Market Share by Application (2021-2026)
2.3.4.2 Global Non-invasive Insulin Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Non-invasive Insulin Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-invasive Insulin Breakdown Data by Company
3.1.1 Global Non-invasive Insulin Annual Sales by Company (2021-2026)
3.1.2 Global Non-invasive Insulin Sales Market Share by Company (2021-2026)
3.2 Global Non-invasive Insulin Annual Revenue by Company (2021-2026)
3.2.1 Global Non-invasive Insulin Revenue by Company (2021-2026)
3.2.2 Global Non-invasive Insulin Revenue Market Share by Company (2021-2026)
3.3 Global Non-invasive Insulin Sale Price by Company
3.4 Key Manufacturers Non-invasive Insulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-invasive Insulin Product Location Distribution
3.4.2 Players Non-invasive Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-INVASIVE INSULIN BY GEOGRAPHIC REGION
4.1 World Historic Non-invasive Insulin Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-invasive Insulin Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-invasive Insulin Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-invasive Insulin Market Size by Country/Region (2021-2026)
4.2.1 Global Non-invasive Insulin Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-invasive Insulin Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-invasive Insulin Sales Growth
4.4 APAC Non-invasive Insulin Sales Growth
4.5 Europe Non-invasive Insulin Sales Growth
4.6 Middle East & Africa Non-invasive Insulin Sales Growth
5 AMERICAS
5.1 Americas Non-invasive Insulin Sales by Country
5.1.1 Americas Non-invasive Insulin Sales by Country (2021-2026)
5.1.2 Americas Non-invasive Insulin Revenue by Country (2021-2026)
5.2 Americas Non-invasive Insulin Sales by Type (2021-2026)
5.3 Americas Non-invasive Insulin Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Insulin Sales by Region
6.1.1 APAC Non-invasive Insulin Sales by Region (2021-2026)
6.1.2 APAC Non-invasive Insulin Revenue by Region (2021-2026)
6.2 APAC Non-invasive Insulin Sales by Type (2021-2026)
6.3 APAC Non-invasive Insulin Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-invasive Insulin by Country
7.1.1 Europe Non-invasive Insulin Sales by Country (2021-2026)
7.1.2 Europe Non-invasive Insulin Revenue by Country (2021-2026)
7.2 Europe Non-invasive Insulin Sales by Type (2021-2026)
7.3 Europe Non-invasive Insulin Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive Insulin by Country
8.1.1 Middle East & Africa Non-invasive Insulin Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-invasive Insulin Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-invasive Insulin Sales by Type (2021-2026)
8.3 Middle East & Africa Non-invasive Insulin Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-invasive Insulin
10.3 Manufacturing Process Analysis of Non-invasive Insulin
10.4 Industry Chain Structure of Non-invasive Insulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-invasive Insulin Distributors
11.3 Non-invasive Insulin Customer
12 WORLD FORECAST REVIEW FOR NON-INVASIVE INSULIN BY GEOGRAPHIC REGION
12.1 Global Non-invasive Insulin Market Size Forecast by Region
12.1.1 Global Non-invasive Insulin Forecast by Region (2027-2032)
12.1.2 Global Non-invasive Insulin Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-invasive Insulin Forecast by Type (2027-2032)
12.7 Global Non-invasive Insulin Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Non-invasive Insulin Product Portfolios and Specifications
13.1.3 Novo Nordisk Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Non-invasive Insulin Product Portfolios and Specifications
13.2.3 Sanofi Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Eli Lilly
13.3.1 Eli Lilly Company Information
13.3.2 Eli Lilly Non-invasive Insulin Product Portfolios and Specifications
13.3.3 Eli Lilly Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Eli Lilly Main Business Overview
13.3.5 Eli Lilly Latest Developments
13.4 MannKind Corporation
13.4.1 MannKind Corporation Company Information
13.4.2 MannKind Corporation Non-invasive Insulin Product Portfolios and Specifications
13.4.3 MannKind Corporation Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MannKind Corporation Main Business Overview
13.4.5 MannKind Corporation Latest Developments
13.5 Biocon
13.5.1 Biocon Company Information
13.5.2 Biocon Non-invasive Insulin Product Portfolios and Specifications
13.5.3 Biocon Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Biocon Main Business Overview
13.5.5 Biocon Latest Developments
13.6 Janssen Pharmaceuticals
13.6.1 Janssen Pharmaceuticals Company Information
13.6.2 Janssen Pharmaceuticals Non-invasive Insulin Product Portfolios and Specifications
13.6.3 Janssen Pharmaceuticals Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Janssen Pharmaceuticals Main Business Overview
13.6.5 Janssen Pharmaceuticals Latest Developments
13.7 Adocia
13.7.1 Adocia Company Information
13.7.2 Adocia Non-invasive Insulin Product Portfolios and Specifications
13.7.3 Adocia Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Adocia Main Business Overview
13.7.5 Adocia Latest Developments
13.8 Oramed Pharmaceuticals
13.8.1 Oramed Pharmaceuticals Company Information
13.8.2 Oramed Pharmaceuticals Non-invasive Insulin Product Portfolios and Specifications
13.8.3 Oramed Pharmaceuticals Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Oramed Pharmaceuticals Main Business Overview
13.8.5 Oramed Pharmaceuticals Latest Developments
13.9 Dance Biopharm
13.9.1 Dance Biopharm Company Information
13.9.2 Dance Biopharm Non-invasive Insulin Product Portfolios and Specifications
13.9.3 Dance Biopharm Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Dance Biopharm Main Business Overview
13.9.5 Dance Biopharm Latest Developments
13.10 Medtronic
13.10.1 Medtronic Company Information
13.10.2 Medtronic Non-invasive Insulin Product Portfolios and Specifications
13.10.3 Medtronic Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Medtronic Main Business Overview
13.10.5 Medtronic Latest Developments
13.11 Verily Life Sciences
13.11.1 Verily Life Sciences Company Information
13.11.2 Verily Life Sciences Non-invasive Insulin Product Portfolios and Specifications
13.11.3 Verily Life Sciences Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Verily Life Sciences Main Business Overview
13.11.5 Verily Life Sciences Latest Developments
13.12 Zafgen
13.12.1 Zafgen Company Information
13.12.2 Zafgen Non-invasive Insulin Product Portfolios and Specifications
13.12.3 Zafgen Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zafgen Main Business Overview
13.12.5 Zafgen Latest Developments
13.13 Senseonics
13.13.1 Senseonics Company Information
13.13.2 Senseonics Non-invasive Insulin Product Portfolios and Specifications
13.13.3 Senseonics Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Senseonics Main Business Overview
13.13.5 Senseonics Latest Developments
13.14 Bigfoot Biomedical
13.14.1 Bigfoot Biomedical Company Information
13.14.2 Bigfoot Biomedical Non-invasive Insulin Product Portfolios and Specifications
13.14.3 Bigfoot Biomedical Non-invasive Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Bigfoot Biomedical Main Business Overview
13.14.5 Bigfoot Biomedical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-invasive Insulin Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-invasive Insulin Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pills
Table 4. Major Players of Sprays
Table 5. Major Players of Others
Table 6. Global Non-invasive Insulin Sales by Type (2021-2026) & (K Units)
Table 7. Global Non-invasive Insulin Sales Market Share by Type (2021-2026)
Table 8. Global Non-invasive Insulin Revenue by Type (2021-2026) & ($ million)
Table 9. Global Non-invasive Insulin Revenue Market Share by Type (2021-2026)
Table 10. Global Non-invasive Insulin Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Non-invasive Insulin Sale by Application (2021-2026) & (K Units)
Table 12. Global Non-invasive Insulin Sale Market Share by Application (2021-2026)
Table 13. Global Non-invasive Insulin Revenue by Application (2021-2026) & ($ million)
Table 14. Global Non-invasive Insulin Revenue Market Share by Application (2021-2026)
Table 15. Global Non-invasive Insulin Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Non-invasive Insulin Sales by Company (2021-2026) & (K Units)
Table 17. Global Non-invasive Insulin Sales Market Share by Company (2021-2026)
Table 18. Global Non-invasive Insulin Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Non-invasive Insulin Revenue Market Share by Company (2021-2026)
Table 20. Global Non-invasive Insulin Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Non-invasive Insulin Producing Area Distribution and Sales Area
Table 22. Players Non-invasive Insulin Products Offered
Table 23. Non-invasive Insulin Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Non-invasive Insulin Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Non-invasive Insulin Sales Market Share Geographic Region (2021-2026)
Table 28. Global Non-invasive Insulin Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Non-invasive Insulin Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Non-invasive Insulin Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Non-invasive Insulin Sales Market Share by Country/Region (2021-2026)
Table 32. Global Non-invasive Insulin Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-invasive Insulin Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-invasive Insulin Sales by Country (2021-2026) & (K Units)
Table 35. Americas Non-invasive Insulin Sales Market Share by Country (2021-2026)
Table 36. Americas Non-invasive Insulin Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Non-invasive Insulin Sales by Type (2021-2026) & (K Units)
Table 38. Americas Non-invasive Insulin Sales by Application (2021-2026) & (K Units)
Table 39. APAC Non-invasive Insulin Sales by Region (2021-2026) & (K Units)
Table 40. APAC Non-invasive Insulin Sales Market Share by Region (2021-2026)
Table 41. APAC Non-invasive Insulin Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Non-invasive Insulin Sales by Type (2021-2026) & (K Units)
Table 43. APAC Non-invasive Insulin Sales by Application (2021-2026) & (K Units)
Table 44. Europe Non-invasive Insulin Sales by Country (2021-2026) & (K Units)
Table 45. Europe Non-invasive Insulin Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Non-invasive Insulin Sales by Type (2021-2026) & (K Units)
Table 47. Europe Non-invasive Insulin Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Non-invasive Insulin Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Non-invasive Insulin Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Non-invasive Insulin Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Non-invasive Insulin Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Non-invasive Insulin
Table 53. Key Market Challenges & Risks of Non-invasive Insulin
Table 54. Key Industry Trends of Non-invasive Insulin
Table 55. Non-invasive Insulin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Non-invasive Insulin Distributors List
Table 58. Non-invasive Insulin Customer List
Table 59. Global Non-invasive Insulin Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Non-invasive Insulin Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Non-invasive Insulin Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Non-invasive Insulin Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Non-invasive Insulin Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Non-invasive Insulin Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Non-invasive Insulin Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Non-invasive Insulin Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Non-invasive Insulin Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Non-invasive Insulin Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Non-invasive Insulin Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Non-invasive Insulin Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Non-invasive Insulin Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Non-invasive Insulin Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Novo Nordisk Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 74. Novo Nordisk Non-invasive Insulin Product Portfolios and Specifications
Table 75. Novo Nordisk Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Novo Nordisk Main Business
Table 77. Novo Nordisk Latest Developments
Table 78. Sanofi Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Non-invasive Insulin Product Portfolios and Specifications
Table 80. Sanofi Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Eli Lilly Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly Non-invasive Insulin Product Portfolios and Specifications
Table 85. Eli Lilly Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. MannKind Corporation Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 89. MannKind Corporation Non-invasive Insulin Product Portfolios and Specifications
Table 90. MannKind Corporation Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. MannKind Corporation Main Business
Table 92. MannKind Corporation Latest Developments
Table 93. Biocon Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 94. Biocon Non-invasive Insulin Product Portfolios and Specifications
Table 95. Biocon Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Biocon Main Business
Table 97. Biocon Latest Developments
Table 98. Janssen Pharmaceuticals Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 99. Janssen Pharmaceuticals Non-invasive Insulin Product Portfolios and Specifications
Table 100. Janssen Pharmaceuticals Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Janssen Pharmaceuticals Main Business
Table 102. Janssen Pharmaceuticals Latest Developments
Table 103. Adocia Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 104. Adocia Non-invasive Insulin Product Portfolios and Specifications
Table 105. Adocia Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Adocia Main Business
Table 107. Adocia Latest Developments
Table 108. Oramed Pharmaceuticals Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 109. Oramed Pharmaceuticals Non-invasive Insulin Product Portfolios and Specifications
Table 110. Oramed Pharmaceuticals Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Oramed Pharmaceuticals Main Business
Table 112. Oramed Pharmaceuticals Latest Developments
Table 113. Dance Biopharm Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 114. Dance Biopharm Non-invasive Insulin Product Portfolios and Specifications
Table 115. Dance Biopharm Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Dance Biopharm Main Business
Table 117. Dance Biopharm Latest Developments
Table 118. Medtronic Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 119. Medtronic Non-invasive Insulin Product Portfolios and Specifications
Table 120. Medtronic Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Medtronic Main Business
Table 122. Medtronic Latest Developments
Table 123. Verily Life Sciences Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 124. Verily Life Sciences Non-invasive Insulin Product Portfolios and Specifications
Table 125. Verily Life Sciences Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Verily Life Sciences Main Business
Table 127. Verily Life Sciences Latest Developments
Table 128. Zafgen Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 129. Zafgen Non-invasive Insulin Product Portfolios and Specifications
Table 130. Zafgen Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Zafgen Main Business
Table 132. Zafgen Latest Developments
Table 133. Senseonics Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 134. Senseonics Non-invasive Insulin Product Portfolios and Specifications
Table 135. Senseonics Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Senseonics Main Business
Table 137. Senseonics Latest Developments
Table 138. Bigfoot Biomedical Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 139. Bigfoot Biomedical Non-invasive Insulin Product Portfolios and Specifications
Table 140. Bigfoot Biomedical Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Bigfoot Biomedical Main Business
Table 142. Bigfoot Biomedical Latest Developments
Table 1. Non-invasive Insulin Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-invasive Insulin Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pills
Table 4. Major Players of Sprays
Table 5. Major Players of Others
Table 6. Global Non-invasive Insulin Sales by Type (2021-2026) & (K Units)
Table 7. Global Non-invasive Insulin Sales Market Share by Type (2021-2026)
Table 8. Global Non-invasive Insulin Revenue by Type (2021-2026) & ($ million)
Table 9. Global Non-invasive Insulin Revenue Market Share by Type (2021-2026)
Table 10. Global Non-invasive Insulin Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Non-invasive Insulin Sale by Application (2021-2026) & (K Units)
Table 12. Global Non-invasive Insulin Sale Market Share by Application (2021-2026)
Table 13. Global Non-invasive Insulin Revenue by Application (2021-2026) & ($ million)
Table 14. Global Non-invasive Insulin Revenue Market Share by Application (2021-2026)
Table 15. Global Non-invasive Insulin Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Non-invasive Insulin Sales by Company (2021-2026) & (K Units)
Table 17. Global Non-invasive Insulin Sales Market Share by Company (2021-2026)
Table 18. Global Non-invasive Insulin Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Non-invasive Insulin Revenue Market Share by Company (2021-2026)
Table 20. Global Non-invasive Insulin Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Non-invasive Insulin Producing Area Distribution and Sales Area
Table 22. Players Non-invasive Insulin Products Offered
Table 23. Non-invasive Insulin Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Non-invasive Insulin Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Non-invasive Insulin Sales Market Share Geographic Region (2021-2026)
Table 28. Global Non-invasive Insulin Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Non-invasive Insulin Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Non-invasive Insulin Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Non-invasive Insulin Sales Market Share by Country/Region (2021-2026)
Table 32. Global Non-invasive Insulin Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-invasive Insulin Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-invasive Insulin Sales by Country (2021-2026) & (K Units)
Table 35. Americas Non-invasive Insulin Sales Market Share by Country (2021-2026)
Table 36. Americas Non-invasive Insulin Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Non-invasive Insulin Sales by Type (2021-2026) & (K Units)
Table 38. Americas Non-invasive Insulin Sales by Application (2021-2026) & (K Units)
Table 39. APAC Non-invasive Insulin Sales by Region (2021-2026) & (K Units)
Table 40. APAC Non-invasive Insulin Sales Market Share by Region (2021-2026)
Table 41. APAC Non-invasive Insulin Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Non-invasive Insulin Sales by Type (2021-2026) & (K Units)
Table 43. APAC Non-invasive Insulin Sales by Application (2021-2026) & (K Units)
Table 44. Europe Non-invasive Insulin Sales by Country (2021-2026) & (K Units)
Table 45. Europe Non-invasive Insulin Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Non-invasive Insulin Sales by Type (2021-2026) & (K Units)
Table 47. Europe Non-invasive Insulin Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Non-invasive Insulin Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Non-invasive Insulin Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Non-invasive Insulin Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Non-invasive Insulin Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Non-invasive Insulin
Table 53. Key Market Challenges & Risks of Non-invasive Insulin
Table 54. Key Industry Trends of Non-invasive Insulin
Table 55. Non-invasive Insulin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Non-invasive Insulin Distributors List
Table 58. Non-invasive Insulin Customer List
Table 59. Global Non-invasive Insulin Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Non-invasive Insulin Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Non-invasive Insulin Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Non-invasive Insulin Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Non-invasive Insulin Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Non-invasive Insulin Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Non-invasive Insulin Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Non-invasive Insulin Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Non-invasive Insulin Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Non-invasive Insulin Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Non-invasive Insulin Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Non-invasive Insulin Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Non-invasive Insulin Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Non-invasive Insulin Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Novo Nordisk Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 74. Novo Nordisk Non-invasive Insulin Product Portfolios and Specifications
Table 75. Novo Nordisk Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Novo Nordisk Main Business
Table 77. Novo Nordisk Latest Developments
Table 78. Sanofi Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Non-invasive Insulin Product Portfolios and Specifications
Table 80. Sanofi Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Eli Lilly Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly Non-invasive Insulin Product Portfolios and Specifications
Table 85. Eli Lilly Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. MannKind Corporation Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 89. MannKind Corporation Non-invasive Insulin Product Portfolios and Specifications
Table 90. MannKind Corporation Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. MannKind Corporation Main Business
Table 92. MannKind Corporation Latest Developments
Table 93. Biocon Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 94. Biocon Non-invasive Insulin Product Portfolios and Specifications
Table 95. Biocon Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Biocon Main Business
Table 97. Biocon Latest Developments
Table 98. Janssen Pharmaceuticals Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 99. Janssen Pharmaceuticals Non-invasive Insulin Product Portfolios and Specifications
Table 100. Janssen Pharmaceuticals Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Janssen Pharmaceuticals Main Business
Table 102. Janssen Pharmaceuticals Latest Developments
Table 103. Adocia Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 104. Adocia Non-invasive Insulin Product Portfolios and Specifications
Table 105. Adocia Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Adocia Main Business
Table 107. Adocia Latest Developments
Table 108. Oramed Pharmaceuticals Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 109. Oramed Pharmaceuticals Non-invasive Insulin Product Portfolios and Specifications
Table 110. Oramed Pharmaceuticals Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Oramed Pharmaceuticals Main Business
Table 112. Oramed Pharmaceuticals Latest Developments
Table 113. Dance Biopharm Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 114. Dance Biopharm Non-invasive Insulin Product Portfolios and Specifications
Table 115. Dance Biopharm Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Dance Biopharm Main Business
Table 117. Dance Biopharm Latest Developments
Table 118. Medtronic Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 119. Medtronic Non-invasive Insulin Product Portfolios and Specifications
Table 120. Medtronic Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Medtronic Main Business
Table 122. Medtronic Latest Developments
Table 123. Verily Life Sciences Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 124. Verily Life Sciences Non-invasive Insulin Product Portfolios and Specifications
Table 125. Verily Life Sciences Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Verily Life Sciences Main Business
Table 127. Verily Life Sciences Latest Developments
Table 128. Zafgen Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 129. Zafgen Non-invasive Insulin Product Portfolios and Specifications
Table 130. Zafgen Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Zafgen Main Business
Table 132. Zafgen Latest Developments
Table 133. Senseonics Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 134. Senseonics Non-invasive Insulin Product Portfolios and Specifications
Table 135. Senseonics Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Senseonics Main Business
Table 137. Senseonics Latest Developments
Table 138. Bigfoot Biomedical Basic Information, Non-invasive Insulin Manufacturing Base, Sales Area and Its Competitors
Table 139. Bigfoot Biomedical Non-invasive Insulin Product Portfolios and Specifications
Table 140. Bigfoot Biomedical Non-invasive Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Bigfoot Biomedical Main Business
Table 142. Bigfoot Biomedical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Non-invasive Insulin
Figure 2. Non-invasive Insulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-invasive Insulin Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Non-invasive Insulin Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-invasive Insulin Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-invasive Insulin Sales Market Share by Country/Region (2025)
Figure 10. Non-invasive Insulin Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Pills
Figure 12. Product Picture of Sprays
Figure 13. Product Picture of Others
Figure 14. Global Non-invasive Insulin Sales Market Share by Type in 2026
Figure 15. Global Non-invasive Insulin Revenue Market Share by Type (2021-2026)
Figure 16. Non-invasive Insulin Consumed in Hospital Pharmacies
Figure 17. Global Non-invasive Insulin Market: Hospital Pharmacies (2021-2026) & (K Units)
Figure 18. Non-invasive Insulin Consumed in Online Pharmacies
Figure 19. Global Non-invasive Insulin Market: Online Pharmacies (2021-2026) & (K Units)
Figure 20. Non-invasive Insulin Consumed in Drug Stores
Figure 21. Global Non-invasive Insulin Market: Drug Stores (2021-2026) & (K Units)
Figure 22. Global Non-invasive Insulin Sale Market Share by Application (2025)
Figure 23. Global Non-invasive Insulin Revenue Market Share by Application in 2026
Figure 24. Non-invasive Insulin Sales by Company in 2026 (K Units)
Figure 25. Global Non-invasive Insulin Sales Market Share by Company in 2026
Figure 26. Non-invasive Insulin Revenue by Company in 2026 ($ millions)
Figure 27. Global Non-invasive Insulin Revenue Market Share by Company in 2026
Figure 28. Global Non-invasive Insulin Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Non-invasive Insulin Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Non-invasive Insulin Sales 2021-2026 (K Units)
Figure 31. Americas Non-invasive Insulin Revenue 2021-2026 ($ millions)
Figure 32. APAC Non-invasive Insulin Sales 2021-2026 (K Units)
Figure 33. APAC Non-invasive Insulin Revenue 2021-2026 ($ millions)
Figure 34. Europe Non-invasive Insulin Sales 2021-2026 (K Units)
Figure 35. Europe Non-invasive Insulin Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Non-invasive Insulin Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Non-invasive Insulin Revenue 2021-2026 ($ millions)
Figure 38. Americas Non-invasive Insulin Sales Market Share by Country in 2026
Figure 39. Americas Non-invasive Insulin Revenue Market Share by Country (2021-2026)
Figure 40. Americas Non-invasive Insulin Sales Market Share by Type (2021-2026)
Figure 41. Americas Non-invasive Insulin Sales Market Share by Application (2021-2026)
Figure 42. United States Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Non-invasive Insulin Sales Market Share by Region in 2026
Figure 47. APAC Non-invasive Insulin Revenue Market Share by Region (2021-2026)
Figure 48. APAC Non-invasive Insulin Sales Market Share by Type (2021-2026)
Figure 49. APAC Non-invasive Insulin Sales Market Share by Application (2021-2026)
Figure 50. China Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 54. India Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Non-invasive Insulin Sales Market Share by Country in 2026
Figure 58. Europe Non-invasive Insulin Revenue Market Share by Country (2021-2026)
Figure 59. Europe Non-invasive Insulin Sales Market Share by Type (2021-2026)
Figure 60. Europe Non-invasive Insulin Sales Market Share by Application (2021-2026)
Figure 61. Germany Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 62. France Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Non-invasive Insulin Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Non-invasive Insulin Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Non-invasive Insulin Sales Market Share by Application (2021-2026)
Figure 69. Egypt Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Non-invasive Insulin in 2026
Figure 75. Manufacturing Process Analysis of Non-invasive Insulin
Figure 76. Industry Chain Structure of Non-invasive Insulin
Figure 77. Channels of Distribution
Figure 78. Global Non-invasive Insulin Sales Market Forecast by Region (2027-2032)
Figure 79. Global Non-invasive Insulin Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Non-invasive Insulin Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Non-invasive Insulin Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Non-invasive Insulin Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Non-invasive Insulin Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Non-invasive Insulin
Figure 2. Non-invasive Insulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-invasive Insulin Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Non-invasive Insulin Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-invasive Insulin Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-invasive Insulin Sales Market Share by Country/Region (2025)
Figure 10. Non-invasive Insulin Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Pills
Figure 12. Product Picture of Sprays
Figure 13. Product Picture of Others
Figure 14. Global Non-invasive Insulin Sales Market Share by Type in 2026
Figure 15. Global Non-invasive Insulin Revenue Market Share by Type (2021-2026)
Figure 16. Non-invasive Insulin Consumed in Hospital Pharmacies
Figure 17. Global Non-invasive Insulin Market: Hospital Pharmacies (2021-2026) & (K Units)
Figure 18. Non-invasive Insulin Consumed in Online Pharmacies
Figure 19. Global Non-invasive Insulin Market: Online Pharmacies (2021-2026) & (K Units)
Figure 20. Non-invasive Insulin Consumed in Drug Stores
Figure 21. Global Non-invasive Insulin Market: Drug Stores (2021-2026) & (K Units)
Figure 22. Global Non-invasive Insulin Sale Market Share by Application (2025)
Figure 23. Global Non-invasive Insulin Revenue Market Share by Application in 2026
Figure 24. Non-invasive Insulin Sales by Company in 2026 (K Units)
Figure 25. Global Non-invasive Insulin Sales Market Share by Company in 2026
Figure 26. Non-invasive Insulin Revenue by Company in 2026 ($ millions)
Figure 27. Global Non-invasive Insulin Revenue Market Share by Company in 2026
Figure 28. Global Non-invasive Insulin Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Non-invasive Insulin Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Non-invasive Insulin Sales 2021-2026 (K Units)
Figure 31. Americas Non-invasive Insulin Revenue 2021-2026 ($ millions)
Figure 32. APAC Non-invasive Insulin Sales 2021-2026 (K Units)
Figure 33. APAC Non-invasive Insulin Revenue 2021-2026 ($ millions)
Figure 34. Europe Non-invasive Insulin Sales 2021-2026 (K Units)
Figure 35. Europe Non-invasive Insulin Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Non-invasive Insulin Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Non-invasive Insulin Revenue 2021-2026 ($ millions)
Figure 38. Americas Non-invasive Insulin Sales Market Share by Country in 2026
Figure 39. Americas Non-invasive Insulin Revenue Market Share by Country (2021-2026)
Figure 40. Americas Non-invasive Insulin Sales Market Share by Type (2021-2026)
Figure 41. Americas Non-invasive Insulin Sales Market Share by Application (2021-2026)
Figure 42. United States Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Non-invasive Insulin Sales Market Share by Region in 2026
Figure 47. APAC Non-invasive Insulin Revenue Market Share by Region (2021-2026)
Figure 48. APAC Non-invasive Insulin Sales Market Share by Type (2021-2026)
Figure 49. APAC Non-invasive Insulin Sales Market Share by Application (2021-2026)
Figure 50. China Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 54. India Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Non-invasive Insulin Sales Market Share by Country in 2026
Figure 58. Europe Non-invasive Insulin Revenue Market Share by Country (2021-2026)
Figure 59. Europe Non-invasive Insulin Sales Market Share by Type (2021-2026)
Figure 60. Europe Non-invasive Insulin Sales Market Share by Application (2021-2026)
Figure 61. Germany Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 62. France Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Non-invasive Insulin Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Non-invasive Insulin Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Non-invasive Insulin Sales Market Share by Application (2021-2026)
Figure 69. Egypt Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Non-invasive Insulin Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Non-invasive Insulin in 2026
Figure 75. Manufacturing Process Analysis of Non-invasive Insulin
Figure 76. Industry Chain Structure of Non-invasive Insulin
Figure 77. Channels of Distribution
Figure 78. Global Non-invasive Insulin Sales Market Forecast by Region (2027-2032)
Figure 79. Global Non-invasive Insulin Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Non-invasive Insulin Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Non-invasive Insulin Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Non-invasive Insulin Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Non-invasive Insulin Revenue Market Share Forecast by Application (2027-2032)
